Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ark Clinical Research is a leading multi-therapeutic clinical research site specializing in late phase (mainly Phase 2, 3, and 4) outpatient clinical trials across multiple indications. It has contributed to the approval of major vaccines and monoclonal antibodies in COVID-19, RSV, and metabolic diseases, frequently serving as a top enrolling site and collaborating on studies resulting in successful regulatory approvals in the US, Europe, and Japan. The company is recognized for excellence in patient recruitment, community engagement (mobile units), and high-quality data[4][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ark Clinical Research.